yth2206游艇会
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2019.03.19
2019年第一次临时股东大会的法律意见书
2019.03.19
2019年第一次临时股东大会决议公告
2019.03.14
关于控股子公司获得GMP证书的公告
2019.03.01
关于召开2019年第一次临时股东大会的通知公告
2019.03.01
关于为非公开发行公司债券追加增信措施并提供反担保的公告
2019.03.01
第四届董事会第二十次会议决议公告
2019.03.01
第四届监事会第十五次会议决议公告
2019.03.01
关于继续申请内保外贷暨为全资子公司提供反担保的公告
2019.03.01
关于使用自有资金购买低风险理财产品的公告
2019.02.28
2018年度业绩快报
第一页
上一页
50
51
52
53
54
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.